Safety and efficacy of conversion therapy for esophageal squamous cell carcinoma.

被引:0
|
作者
Tsuji, Takayuki
Kawakubo, Hirofumi
Takeuchi, Masashi
Matsuda, Satoru
Fukuda, Kazumasa
Nakamura, Rieko
Kitagawa, Yuko
机构
[1] Keio Univ, Sch Med, Shinjuku Ku, Tokyo, Japan
[2] Keio Univ, Div Gen & Gastroenterol Surg, Sch Med, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
362
引用
下载
收藏
页码:362 / 362
页数:1
相关论文
共 50 条
  • [1] Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable esophageal squamous cell carcinoma.
    Yoshinami, Yuri
    Yamamoto, Shun
    Kadono, Toru
    Hirose, Toshiharu
    Ikeda, Go
    Ohara, Akihiro
    Itoyama, Mai
    Yokoyama, Kazuki
    Honma, Yoshitaka
    Ishiyama, Koshiro
    Oguma, Junya
    Daiko, Hiroyuki
    Kato, Ken
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 373 - 373
  • [2] The efficacy and safety of FOLFOX therapy for advanced esophageal squamous cell carcinoma
    Kazuhiro Shiraishi
    Mao Okada
    Shun Yamamoto
    Yuki Matsubara
    Toshiki Masuishi
    Keitaro Shimozaki
    Yoshiyuki Yamamoto
    Suguru Hirose
    Keiji Sugiyama
    Mitsuhiro Furuta
    Nozomu Machida
    Naoki Takahashi
    Takako Yoshii
    Yosuke Kito
    Takao Tsuzuki
    Shogen Boku
    Kenji Tsuchihashi
    Akinori Sugaya
    Toshizo Takayama
    Azusa Komori
    Seiichiro Mitani
    Toshihiko Matsumoto
    Takashi Nishimura
    Kenro Hirata
    Scientific Reports, 15 (1)
  • [3] Efficacy and safety of endoscopic submucosal dissection in elderly patients with esophageal squamous cell carcinoma.
    Shin, In Seub
    Song, Byeong Geun
    Kim, Doyeon
    Lee, Hyuk
    Min, Byung-Hoon
    Lee, Jun Haeng
    Rhee, Poong-Lyul
    Kim, Jae J.
    Min, Yang Won
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [4] Safety and efficacy of nivolumab therapy in patients with advanced esophageal squamous cell carcinoma
    Shimada, Seitaro
    Tsushima, Takahiro
    Shirasu, Hiromichi
    Kawakami, Takeshi
    Hamauchi, Satoshi
    Todaka, Akiko
    Yokota, Tomoya
    Yamazaki, Kentaro
    Fukutomi, Akira
    Onozawa, Yusuke
    Yasui, Hirofumi
    ANNALS OF ONCOLOGY, 2021, 32 : S328 - S328
  • [5] Defining conversion therapy for esophageal squamous cell carcinoma
    Matsuda, Satoru
    Tsushima, Takahiro
    Kato, Ken
    Hsu, Chih-Hung
    Lee, Jang Ming
    Wong, Ian Yu-Hong
    Wang, Hu-Lin Christina
    Kang, Chang Hyun
    Guo, Xufeng
    Yamamoto, Shun
    Tsuji, Takayuki
    Kawakubo, Hirofumi
    Takeuchi, Hiroya
    Law, Simon
    Kitagawa, Yuko
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2023, 7 (01): : 7 - 9
  • [6] The efficacy and safety of toripalimab combined with definitive chemoradiotherapy for patients with locally advanced esophageal squamous cell carcinoma.
    Xi, Mian
    Zhu, Yujia
    Li, Qiao-Qiao
    Zhao, Lei
    Yang, Yadi
    Hu, Yonghong
    Liu, Mengzhong
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Efficacy and safety of apatinib with or without radiotherapy as second-line or beyond therapy in patients with advanced/recurrent esophageal squamous cell carcinoma.
    Lv, Jiahua
    Li, Tao
    Wang, Qifeng
    Fan, Yu
    Wang, Junchao
    Lang, Jinyi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Efficacy and safety of endostar in the treatment of advanced lung squamous cell carcinoma.
    Hu, Weiheng
    Fang, Jian
    Nie, Jun
    Dai, Ling
    Zhang, Jie
    Chen, Xiaoling
    Ma, Xiangjuan
    Tan, Guangming
    Wu, Di
    Han, Jindi
    Han, Sen
    Wang, Yang
    Long, Jieran
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] The efficacy and safety of neoadjuvant sintilimab combined with chemotherapy in elderly patients with locally advanced esophageal squamous cell carcinoma.
    Lv, Huilai
    Huang, Chao
    Li, Jiachen
    Zhang, Fan
    Gai, Chunyue
    Liu, Zhao
    Xu, Shi
    Wang, Mingbo
    Li, Zhenhua
    Tian, Ziqiang
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 378 - 378
  • [10] The overall safety and short-term efficacy of nivolumab plus ipilimumab for advanced esophageal squamous cell carcinoma.
    Shiraishi, Kazuhiro
    Yamamoto, Shun
    Yoshinami, Yuri
    Ohara, Akihiro
    Itoyama, Mai
    Yokoyama, Kazuki
    Honma, Yoshitaka
    Kashiraha, Tairo
    Kurita, Daisuke
    Ishiyama, Koshiro
    Oguma, Junya
    Igaki, Hiroshi
    Daiko, Hiroyuki
    Kato, Ken
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 329 - 329